Moors & Cabot’s AllianzIM U.S. Equity Buffer10 Dec ETF DECT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,560
Closed -$203K 900
2025
Q1
$203K Sell
6,560
-500
-7% -$16K 0.01% 782
2024
Q4
$225K Sell
7,060
-800
-10% -$25.7K 0.01% 768
2024
Q3
$250K Sell
7,860
-500
-6% -$15.7K 0.01% 715
2024
Q2
$260K Sell
8,360
-200
-2% -$6.06K 0.01% 675
2024
Q1
$258K Buy
8,560
+1,560
+22% +$45.7K 0.01% 722
2023
Q4
$200K Buy
+7,000
New +$190K 0.01% 753

Other funds holding DECT

Moors & Cabot's DECT Position: Q2 2025 in Review

Moors & Cabot sold out of AllianzIM U.S. Equity Buffer10 Dec ETF (DECT) in Q2 2025, closing a stake of 6,560 shares — an estimated $203K sold.

Moors & Cabot first reported a position in DECT in Q4 2023 and held it in 6 quarters. The position peaked at $260K in Q2 2024. 40 funds tracked by Wall St. Rank hold DECT as of Q2 2025.

  • Moors & Cabot reported no remaining AllianzIM U.S. Equity Buffer10 Dec ETF position as of Q2 2025 after selling out during the quarter.
  • Moors & Cabot sold 6,560 AllianzIM U.S. Equity Buffer10 Dec ETF shares in Q2 2025, an estimated $203K.
  • Moors & Cabot first reported a position in AllianzIM U.S. Equity Buffer10 Dec ETF in Q4 2023 and held it in 6 quarters.
  • Moors & Cabot's AllianzIM U.S. Equity Buffer10 Dec ETF position peaked at $260K in Q2 2024.
  • 40 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer10 Dec ETF as of Q2 2025.

Based on Moors & Cabot's 13F filing for Q2 2025, filed 6 Aug 2025.